Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 13 results found. Search for [ GSK Velu ]

Results 1 to 13 of 13
PB Jayakumar
New Delhi, April 13, 2020
Sources said the ICMR's initial orders for 5 lakh kits included the Chinese firm Wondfo, which has the NMPA clearance. Nevertheless the firm did not honour its commitment


PB Jayakumar
April 4, 2020
Trivitron, which has nine manufacturing facilities across five locations -- Chennai, Mumbai, Pune, Ankara and Helsinki, will manufacture the COVID-19 products at its main facility in Chennai and at Vizag in Andhra Pradesh


Joe C Mathew
March 25, 2020
The company said it will scale up its capacity up to 2,000 to 2,500 tests per day as per ICMR guidelines by next week


PB Jayakumar
January 30, 2020
Budget 2020 expectations: The healthcare industry also wants the allocation for the sector to go up as the government had promised to earmark 2.5 per cent of the GDP in the National Health Policy


PB Jayakumar
New Delhi, July 19, 2019
Failed policies cause domestic manufactures to import medical devices, while the government wants India to list among top five medical devices manufacturing hubs in the world under the 'Make in India' initiative


PTI
February 21, 2019



PTI
January 29, 2019



PTI
October 7, 2018



P.B. Jayakumar
New Delhi, September 3, 2018
Ameera Shah turned her father's nondescript clinic into one of the largest pathology chains in India.


PTI
March 11, 2018



PB Jayakumar
New Delhi, November 2, 2017
Local medical devices makers who  are facing a tough run, as lack of regulations, government support, tax structure and price control are squeezing their margins and growth, besides competition from MNCs.


PTI
New Delhi, September 9, 2015
An affiliate of Carlyle Asia Partners IV has bought a stake in Metropolis Healthcare Ltd, a multinational chain of pathology laboratories, Carlyle Group said in a statement.


PB Jayakumar
January 14, 2015
\"I still own 38 per cent stake in Metropolis and there is no need to sell my stake at this point of time, as the company is on a growth trajectory\", said GSK Velu.


PAGES 1 OF 1